Yuflyma

Active Ingredient(s): Adalimumab-aaty
FDA Approved: * May 23, 2023
Pharm Company: * CELLTRION
Category: Immunosuppressive

Adalimumab, sold under the brand name Humira, among others, is a monoclonal antibody used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis.[5][6][7] It is administered by injection under the skin.[5] Common side effects include upper respiratory tract infections, pain at the site o... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Yuflyma 80 mg/.8ml Subcutaneous Injection
NDC: 72606-023
Labeler:
Celltrion USA, Inc.
Yuflyma 20 mg/.2ml Subcutaneous Injection
NDC: 72606-024
Labeler:
Celltrion USA, Inc.
Yuflyma 40 mg/.4ml Subcutaneous Injection
NDC: 72606-030
Labeler:
Celltrion USA, Inc.
YuflymaYuflyma Kit
NDC: 72606-039
Labeler:
Celltrion USA, Inc.
YuflymaYuflyma Kit
NDC: 72606-046
Labeler:
Celltrion USA, Inc.

Related Brands

Drugs with the same active ingredients